S&S Endo Inc provides comprehensive diabetes care from its Miami office with telehealth follow-up when appropriate. Irina C. Delgado Varela, MD evaluates blood sugar patterns, medications, technology options, and related health risks to build a plan that fits each patient's medical needs.
Diabetes develops when the body cannot make enough insulin, cannot use insulin effectively, or both. Insulin helps move glucose from the bloodstream into cells for energy. When glucose stays high over time, it can affect the heart, kidneys, nerves, eyes, and circulation.
Evaluation may include A1C testing, fasting glucose, review of home glucose readings, kidney and cholesterol testing, and discussion of individualized glucose and A1C goals. A1C reflects average blood sugar over about three months and helps guide treatment decisions.
Consider endocrine care if your blood sugar remains above goal, you have frequent hypoglycemia, you use insulin or a pump, you are considering a CGM, or diabetes is occurring with obesity, kidney disease, neuropathy, high cholesterol, or other endocrine concerns.
Patients receive physician-directed diabetes care in Miami with attention to glucose data, medication safety, prevention of complications, and practical follow-up. Telehealth may be available for eligible follow-up visits in Florida.
Board-certified in Internal Medicine; Endocrinology, Diabetes & Metabolism; and Obesity Medicine. Last reviewed/updated: 2026-09-22
You should consider an endocrinologist if diabetes is newly diagnosed, difficult to control, associated with frequent low blood sugar, or requires insulin, a CGM, or an insulin pump.
An A1C of 6.5% or higher is commonly used to diagnose diabetes, while 5.7% to 6.4% is considered prediabetes. Your clinician interprets results with your full medical picture.
Many patients have A1C checked about every three months when treatment is changing or glucose is above goal, and less often when diabetes is stable.
Type 1 diabetes is usually caused by autoimmune loss of insulin production. Type 2 diabetes is commonly related to insulin resistance and progressive changes in insulin production.
Insulin resistance means the body's cells do not respond to insulin efficiently, so the pancreas must make more insulin to keep blood sugar controlled.
Some people can reach blood sugar levels below the diabetes range with sustained weight loss and treatment, but ongoing monitoring remains important.
A continuous glucose monitor, or CGM, is a wearable sensor that tracks glucose trends throughout the day and night.
CGM eligibility depends on diabetes type, insulin use, glucose variability, hypoglycemia risk, and insurance rules.
An insulin pump may be used when frequent insulin dosing is needed and the patient can safely manage pump therapy with clinical support.
Yes. S&S Endo can help appropriate patients with insulin pump review, settings, glucose pattern analysis, and ongoing insulin management.
Weight loss can improve insulin resistance and blood sugar control for many people with Type 2 diabetes, though results vary and care should be individualized.
Prediabetes can often improve with weight management, nutrition changes, activity, and sometimes medication, but continued monitoring is important.
Coverage varies by plan and clinical criteria. The office can help patients understand documentation needs for CGMs or insulin pumps.
Contact: (305) 209-2191 | 7392 NW 35th Terrace, Suite 306, Miami, FL 33122